中国普外基础与临床杂志

中国普外基础与临床杂志

IgG4 硬化性胆管炎误诊为肝门胆管癌及术后消化道出血 MDT 讨论

查看全文

目的 探讨免疫球蛋白 G4 硬化性胆管炎(IgG4SC)误诊为肝门胆管癌以及术后胃十二指肠假性动脉瘤破裂的临床表现、诊断和治疗措施,以提高对该病的认识及合理诊治。 方法 回顾性分析四川大学华西医院诊治的 1 例 IgG4SC 误诊为肝门胆管癌且术后消化道出血患者的临床资料。 结果 该例患者以肝门胆管癌收入院,术前影像学检查表现为典型的肝门胆管癌影像学特征,遂行肝门胆管癌根治术,术后病理结果诊断为 IgG4SC,补查血清 IgG4 仅轻度升高。术后 1 个月突发呕血,动脉造影显示胃十二指肠假性动脉瘤破裂出血,经栓塞治疗后痊愈。 结论 术前诊断 IgG4SC 较为困难,特别应与肝门胆管癌鉴别,可避免不必要的手术。胃十二指肠假性动脉瘤形成的原因主要是胃十二指肠动脉术中被损伤,肝胆疾病手术行动脉骨骼化过程中需注意动脉保护。临床怀疑假性动脉瘤形成时,应尽早行血管介入诊断并同时行栓塞治疗。

Objective To explore clinical manifestation, diagnosis and treatment of IgG4 sclerosing cholangitis developed postoperative gastroduodenal hemorrhage, so as to improve awareness and treatment of this disease. Method The clinical data of a case of IgG4 sclerosing cholangitis misdiagnosed as the hilar cholangiocarcinoma which developed postoperative gastrointestinal hemorrhage in this hospital were analyzed retrospectively. Results This patient was misdiagnosed as the hilar cholangiocarcinoma and accepted the radical resection, while the postoperative pathology proved to be the IgG4 sclerosing cholangitis. One month later, the patient developed the acute gastrointestinal hemorrhage and it was resolved by using the endovascular embolization. Conclusions Preoperative distinguishing IgG4 sclerosing cholangitis from hilar cholangiocarcinoma can avoid an unnecessary surgery. Endovascular intervention is both a useful measure of diagnosis and treatment for gastroduodenal pseudoaneurysm. Attention should be paid to arterial protection during process of arterial osteogenesis in hepatobiliary operation.

关键词: IgG4 硬化性胆管炎; 肝门胆管癌; 胃十二指肠假性动脉瘤

Key words: IgG4 sclerosing cholangitis; hilar cholangiocarcinoma; gastroduodenal pseudoaneurysm

引用本文: 冉从盾, 靳艳文, 黄子星, 李富宇. IgG4 硬化性胆管炎误诊为肝门胆管癌及术后消化道出血 MDT 讨论. 中国普外基础与临床杂志, 2019, 26(1): 86-91. doi: 10.7507/1007-9424.201810010 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol, 2004, 28(9): 1193-1203.
2. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology, 2008, 134(3): 706-715.
3. Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet, 2015, 385(9976): 1460-1471.
4. Roos E, Hubers LM, Coelen RJS, et al. IgG4-associated cholangitis in patients resected for presumed perihilar cholangiocarcinoma: a 30-year tertiary care experience. Am J Gastroenterol, 2018, 113(5): 765-772.
5. Geary K, Yazici C, Seibold A, et al. IgG4-related cholangiopathy and its mimickers: a case report and review highlighting the importance of early diagnosis. Int J Surg Pathol, 2018, 26(2): 165-173.
6. Tanaka A, Tazuma S, Okazaki K, et al. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol, 2017, 15(6): 920-926.
7. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol, 2006, 4(8): 1010-1016.
8. Nakazawa T, Naitoh I, Hayashi K, et al. Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol, 2013, 19(43): 7661-7670.
9. Oseini AM, Chaiteerakij R, Shire AM, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology, 2011, 54(3): 940-948.
10. Boonstra K, Culver EL, de Buy Wenniger LM, et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology, 2014, 59(5): 1954-1963.
11. Erdogan D, Kloek JJ, ten Kate FJ, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg, 2008, 95(6): 727-734.
12. Tabata T, Kamisawa T, Hara S, et al. Differentiating immunoglobulin G4-related sclerosing cholangitis from hilar cholangiocarcinoma. Gut Liver, 2013, 7(2): 234-238.
13. Navaneethan U, Hasan MK, Kommaraju K, et al. Digital, single-operator cholangiopancreatoscopy in the diagnosis and management of pancreatobiliary disorders: a multicenter clinical experience (with video). Gastrointest Endosc, 2016, 84(4): 649-655.
14. Navaneethan U, Hasan MK, Lourdusamy V, et al. Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointest Endosc, 2015, 82(4): 608-614.
15. Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut, 2013, 62(12): 1771-1776.
16. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut, 2009, 58(11): 1504-1507.
17. Okazaki K, Chari ST, Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology, 2017, 17(1): 1-6.
18. Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 Ⅲ. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol, 2014, 49(6): 961-970.
19. White AF, Baum S, Buranasiri S. Aneurysms secondary to pancreatitis. AJR Am J Roentgenol, 1976, 127(3): 393-396.
20. Morita Y, Kawamura N, Saito H, et al. Diagnosis and embolotherapy of aneurysm of the gastroduodenal artery. Rinsho Hoshasen, 1988, 33(5): 555-561.
21. Kueper MA, Ludescher B, Koenigsrainer I, et al. Successful coil embolization of a ruptured gastroduodenal artery aneurysm. Vasc Endovascular Surg, 2007, 41(6): 568-571.
22. Habib N, Hassan S, Abdou R, et al. Gastroduodenal artery aneurysm, diagnosis, clinical presentation and management: a concise review. Ann Surg Innov Res, 2013, 7(1): 4.
23. Lee PC, Rhee RY, Gordon RY, et al. Management of splenic artery aneurysms: the significance of portal and essential hypertension. J Am Coll Surg, 1999, 189(5): 483-490.
24. Rowsell C, Moore TL, Streutker CJ. Aneurysm of the gastroduodenal artery presenting as a bleeding duodenal ulcer. Clin Gastroenterol Hepatol, 2006, 4(10): xxviii.
25. Harris K, Chalhoub M, Koirala A. Gastroduodenal artery aneurysm rupture in hospitalized patients: An overlooked diagnosis. World J Gastrointest Surg, 2010, 2(9): 291-294.
26. Pilleul F, Beuf O. Diagnosis of splanchnic artery aneurysms and pseudoaneurysms, with special reference to contrast enhanced 3D magnetic resonance angiography: a review. Acta Radiol, 2004, 45(7): 702-708.
27. Frauenfelder T, Wildermuth S, Marincek B, et al. Nontraumatic emergent abdominal vascular conditions: advantages of multi-detector row CT and three-dimensional imaging. Radiographics, 2004, 24(2): 481-496.
28. Yeh TS, Jan YY, Jeng LB, et al. Massive extra-enteric gastrointestinal hemorrhage secondary to splanchnic artery aneurysms. Hepatogastroenterology, 1997, 44(16): 1152-1156.